BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:" Organoids to model human disease”
DTSTART:20231109T121500
DTEND:20231109T133000
DTSTAMP:20260415T011121Z
UID:66bbd20385a52d8493f2f6c60636f25cd7ba364f0a43a62c4fd3575a
CATEGORIES:Conferences - Seminars
DESCRIPTION:Hans Clevers\, Head of Pharma Research and Early Development (
 pRED) at Roche\nA Lola and John Grace Distinguished Lecture in Cancer Rese
 arch\n\nHans Clevers has been the Head of Pharma Research and Early Develo
 pment (pRED) at Roche since 2022. In this role\, he is responsible for the
  strategy\, development and management of all aspects of early research an
 d discovery at pRED\, from lead identification to target progression to la
 te stage development. Earlier this year\, he oversaw the successful establ
 ishment of the Institute of Human Biology\, a key long-term investment to 
 bridge the gap between academic and pharmaceutical research in Basel\, Swi
 tzerland. In addition\, he is a member of the expanded Corporate Executive
  Committee for Roche.\n\nHans Clevers is world-renowned for his work in th
 e fields of cell biology\, molecular signaling and stem cells. His researc
 h groups’ discoveries include the detailed characterization of the molec
 ular effectors and integrators of the “Wnt” pathway\, which play cruci
 al roles in health and disease\, including colon cancer. His group provide
 d important insights into the roles of the LGR5 protein in stem cell regen
 eration. The Clevers’s group pioneered “organoids”\, 3-dimensional i
 n vitro structures that behave anatomically and molecularly like the organ
  from which they are derived. Organoid biology has revolutionized the way 
 we understand and approach human biology and medicine.\n\nHans Clevers obt
 ained his MD and PhD degrees from the University Utrecht\, the Netherlands
 . He holds a professorship in Molecular Genetics from the University Utrec
 ht. He previously held directorship/President positions at the Hubrecht In
 stitute\, the Royal Netherlands Academy of Arts and Sciences and the Princ
 ess Maxima Center for pediatric oncology. He is the recipient of multiple 
 international scientific awards\, including the Breakthrough Prize in Life
  Science.\nHans Clevers is a member of the Royal Netherlands Academy of Ar
 ts and Sciences (NL)\, the National Academy of Sciences (USA)\, the Royal 
 Society (UK) and the Academie des Sciences (France). He is also Chevalier 
 de la Légion d’Honneur and Knight in the Order of the Netherlands Lion\
 , among many other international accolades.\n\n\n 
LOCATION:SV 1717 https://plan.epfl.ch/?room==SV%201717 https://epfl.zoom.u
 s/s/97039045251
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR